Страна: Мальта
мова: англійська
Джерело: HMA (Heads of Medicines Agencies)
cefalonium 250 mg
Intervet UK Limited
QJ51DB90
Intramammary suspension
cefalonium
Cattle Lactating
2012-07-25
Issued: September 2012 AN: 00840/2011 Page 1 of 7 _ _ SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT UK: Kepravine Dry Cow 250 mg Intramammary Suspension AT, CY, DE, EE, LT, LV, MT, NL: Cepravin Dry Cow 250 mg Intramammary Suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION EACH INTRAMAMMARY SYRINGE WITH 3 G SUSPENSION CONTAINS: ACTIVE SUBSTANCE: Cefalonium (as cefalonium dihydrate) 0.25 g For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Intramammary suspension. White to cream coloured suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dairy cattle (cows at drying off). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of subclinical mastitis at drying-off and the prevention of new bacterial infections of the udder caused by _Staphylococcus aureus_, _Streptococcus agalactiae_, _Streptococcus dysgalactiae_, _Streptococcus uberis_, _Arcanobacterium pyogenes_,_ _ _Escherichia coli_ and _Klebsiella spp._ during the non-lactating period of cows. 4.3 CONTRAINDICATIONS Not to be administered to animals which are known to be hypersensitive to cephalosporin antibiotics and other β-lactam antibiotics. Please refer to section 4.7 Issued: September 2012 AN: 00840/2011 Page 2 of 7 4.4 SPECIAL WARNINGS None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Do not bend the nozzle. Do not contaminate the nozzle. Use of the product should be based on susceptibility testing and should take into account official and local antimicrobial policies. Increased use, including use o Прочитайте повний документ